Seoul, South Korea

Keun-Hyung Cho

USPTO Granted Patents = 1 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Transplantation: The Contributions of Keun-Hyung Cho

Introduction

Keun-Hyung Cho is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of transplantation medicine through his innovative research and patent developments. His work focuses on preventing and treating transplant rejection, which is a critical issue in organ transplantation.

Latest Patents

One of Cho's key patents is titled "Composition for preventing and treating transplant rejection or transplant rejection diseases, comprising novel compound and calcineurin inhibitor." This invention relates to a composition that effectively prevents or treats transplantation rejection or related diseases. The composition includes a novel compound and a calcineurin inhibitor, which work together to reduce the activity of pathogenic Th1 and Th17 cells while increasing the activity of Treg cells. Additionally, it has been shown to inhibit various pathogenic pathways and cell death of inflammatory cells, thereby mitigating side effects associated with conventional immunosuppressants. This patent highlights Cho's innovative approach to improving transplant outcomes and reducing complications.

Career Highlights

Keun-Hyung Cho is affiliated with the Catholic University of Korea Industry-Academic Cooperation Foundation. His work in this institution has allowed him to collaborate with other researchers and contribute to advancements in the field of pharmaceutics related to transplantation rejection and immune disorders.

Collaborations

Some of Cho's notable coworkers include Mi-La Cho and Dong-Yun Shin. Their collaborative efforts have further enhanced the research and development of effective treatments for transplant rejection.

Conclusion

Keun-Hyung Cho's innovative contributions to transplantation medicine through his patent on preventing transplant rejection demonstrate his commitment to improving patient outcomes. His work is vital in the ongoing efforts to enhance the success of organ transplants and reduce the risks associated with immunosuppressive therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…